These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 22533524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ.
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [Abstract] [Full Text] [Related]

  • 3. [Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].
    López MF, Mingot ME, Valcárcel D, Vicente García V, Perrin A, Campos Tapias I.
    Med Clin (Barc); 2015 May 08; 144(9):389-96. PubMed ID: 24565604
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.
    Kikuchi K, Miyakawa Y, Ikeda S, Sato Y, Takebayashi T.
    BMC Health Serv Res; 2015 Jan 22; 15():2. PubMed ID: 25609557
    [Abstract] [Full Text] [Related]

  • 7. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
    Mazza P, Minoia C, Melpignano A, Polimeno G, Cascavilla N, Di Renzo N, Specchia G.
    Ann Hematol; 2016 Jan 22; 95(2):239-44. PubMed ID: 26596973
    [Abstract] [Full Text] [Related]

  • 8. Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia.
    Grainger JD, Kühne T, Hippenmeyer J, Cooper N.
    Ann Hematol; 2021 Sep 22; 100(9):2143-2154. PubMed ID: 34308495
    [Abstract] [Full Text] [Related]

  • 9. Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP).
    Bussel JB, Hsieh L, Buchanan GR, Stine K, Kalpatthi R, Gnarra DJ, Ho RH, Nie K, Eisen M.
    Pediatr Blood Cancer; 2015 Feb 22; 62(2):208-213. PubMed ID: 25345874
    [Abstract] [Full Text] [Related]

  • 10. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.
    Watanabe R, Tabayashi T, Tomikawa T, Sagawa M, Anan-Nemoto T, Kimura Y, Takahashi Y, Tokuhira M, Otaki S, Oi H, Sawano M, Sugiyama S, Kizaki M.
    Int J Hematol; 2017 Jan 22; 105(1):100-103. PubMed ID: 27709451
    [Abstract] [Full Text] [Related]

  • 11. Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.
    Atkinson K.
    Clin J Oncol Nurs; 2019 Apr 01; 23(2):212-216. PubMed ID: 30880797
    [Abstract] [Full Text] [Related]

  • 12. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia.
    Lozano ML, Godeau B, Grainger J, Matzdorff A, Rodeghiero F, Hippenmeyer J, Kuter DJ.
    Expert Rev Hematol; 2020 Dec 01; 13(12):1319-1332. PubMed ID: 33249935
    [Abstract] [Full Text] [Related]

  • 13. Plateletpheresis for postsplenectomy rebound thrombocytosis in a patient with chronic immune thrombocytopenic purpura on romiplostim.
    Raval JS, Redner RL, Kiss JE.
    J Clin Apher; 2013 Aug 01; 28(4):321-4. PubMed ID: 23450778
    [Abstract] [Full Text] [Related]

  • 14. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
    Sivera P, Ruella M, Gueli A, Hu H, Wade M, Tarella C.
    Blood Coagul Fibrinolysis; 2012 Jun 01; 23(4):331-4. PubMed ID: 22343685
    [Abstract] [Full Text] [Related]

  • 15. [Cost per responder associated with romiplostim and rituximab treatment for adult primary immune thrombocytopenia in France].
    Chiche L, Perrin A, Stern L, Kutikova L, Cohen-Nizard S, Lefrère F.
    Transfus Clin Biol; 2014 May 01; 21(2):85-93. PubMed ID: 24797790
    [Abstract] [Full Text] [Related]

  • 16. The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital.
    Marquínez-Alonso I, Escudero-Vilaplana V, Pernía S, Beléndez Bieler C, Fernández-Llamazares CM, Sanjurjo-Sáez M.
    J Clin Pharm Ther; 2014 Aug 01; 39(4):376-82. PubMed ID: 24702274
    [Abstract] [Full Text] [Related]

  • 17. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R.
    Am J Hematol; 2016 May 01; 91(5):E293-5. PubMed ID: 26910388
    [Abstract] [Full Text] [Related]

  • 18. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
    Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Pérault-Pochat MC, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P.
    Rev Med Interne; 2017 Mar 01; 38(3):167-175. PubMed ID: 27793553
    [Abstract] [Full Text] [Related]

  • 19. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T, Harada Y, Matsubara E, Suzuki T, Oyama T, Kasai M, Uchida T, Ogura M.
    J Clin Pharm Ther; 2012 Dec 01; 37(6):729-32. PubMed ID: 22583038
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.